Author:
Haroche Julien,Arnaud Laurent,Cohen-Aubart Fleur,Hervier Baptiste,Charlotte Frédéric,Emile Jean-François,Amoura Zahir
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Chester W. Über lipoidgranulomatose. Virchows Arch Pathol Anat. 1930;279:561–602.
2. Adam Z, Koukalova R, Sprlakova A, et al. Successful treatment of Erdheim–Chester disease by 2-chlorodeoxyadenosine-based chemotherapy. Two case studies and a literature review. Vnitr Lek. 2011;57:576–89.
3. Haroche J, Arnaud L, Amoura Z. Erdheim–Chester disease. Curr Opin Rheumatol. 2012;24:53–9.
4. Arnaud L, Hervier B, Neel A, et al. CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim–Chester disease: a multicenter survival analysis of 53 patients. Blood. 2011;117:2778–82. This is a major study, with the largest description of ECD series to date, describing the efficacy of interferon alpha, a major independent predictor of survival, and the importance of CNS involvement, a major prognostic factor and an independent predictor of death in ECD.
5. Haroche J, Amoura Z, Dion E, et al. Cardiovascular involvement, an overlooked feature of Erdheim–Chester disease: report of 6 new cases and a literature review. Medicine (Baltimore). 2004;83:371–92.
Cited by
113 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献